N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142708 |
| CAS No | NA |
| Mol.F. | C14H19N3O2 |
| Mol.Wt. | 261.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142709 |
| CAS No | NA |
| Mol.F. | C14H13N3O2 |
| Mol.Wt. | 255.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142710 |
| CAS No | NA |
| Mol.F. | C15H20ClN3O2 |
| Mol.Wt. | 309.79 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142711 |
| CAS No | NA |
| Mol.F. | C15H21N3O3 |
| Mol.Wt. | g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142712 |
| CAS No | NA |
| Mol.F. | C18H22N4O2 |
| Mol.Wt. | 326.39 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142713 |
| CAS No | NA |
| Mol.F. | C18H22N4O2 |
| Mol.Wt. | 326.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142714 |
| CAS No | NA |
| Mol.F. | C27H21Cl2N5O |
| Mol.Wt. | 502.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142715 |
| CAS No | NA |
| Mol.F. | C27H22ClN5O |
| Mol.Wt. | 467.96 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142716 |
| CAS No | NA |
| Mol.F. | C24H14Cl2N4O2 |
| Mol.Wt. | 461.30 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142717 |
| CAS No | NA |
| Mol.F. | C12H10ClN3O |
| Mol.Wt. | 247.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142718 |
| CAS No | NA |
| Mol.F. | C24H15Cl2N5O |
| Mol.Wt. | 460.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142719 |
| CAS No | NA |
| Mol.F. | C27H22ClN5O |
| Mol.Wt. | 467.96 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142720 |
| CAS No | NA |
| Mol.F. | C12H8ClN3O3 |
| Mol.Wt. | 277.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142721 |
| CAS No | NA |
| Mol.F. | C24H19Cl2N5O |
| Mol.Wt. | 464.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142722 |
| CAS No | NA |
| Mol.F. | C24H19Cl2N5O |
| Mol.Wt. | 464.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142723 |
| CAS No | NA |
| Mol.F. | C24H16ClN5O |
| Mol.Wt. | 425.88 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |